The latest announcement of Zhongsheng Pharmaceutical: the first subject of the Phase III clinical trial of the subsidiary’s first-class innovative drug ZSP1273 has been enrolled_Stock News_Market_Zhongjin Online

Key Data Concepts:   

? These are the company names, stock quotes, topics, and entities related to this data.

002317 China Shipbuilding Industry Group Power Citic Securities Fujian Funeng Guangdong Zhongsheng Pharmaceutical Xinjiang Sayram Modern Agriculture Research, Development Pharmaceutical Retail Market, Exchange Securities Biotechnology Adults Economy, Business, Finance

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Home » News » The latest announcement of Zhongsheng Pharmaceutical: the first subject of the Phase III clinical trial of the subsidiary’s first-class innovative drug ZSP1273 has been enrolled_Stock News_Market_Zhongjin Online